Register entry

Cosmo SpA

Data as of · How to read this entry

Registered sites
1
Active NDC listings
4
Live patents
0
Countries
1
Base
Italy
Authorisation

Registered operations

Analytical testing1Finished drug manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Cosmo SpAVIA CRISTOFORO COLOMBO 1, LAINATE, MILANO 20045, Italy (ITA)Analytical testing, Finished drug manufacture3004504760630431955
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 4.

Dosage formNDCs
tablet, film coated2
tablet, delayed release1
tablet, extended release1
RouteNDCs
Labeller name on the listingNDCs
cosmo spa4
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
-NALOXEGOL OXALATEtablet, film coated68743-881DRUG FOR FURTHER PROCESSING
-NALOXEGOL OXALATEtablet, film coated68743-882DRUG FOR FURTHER PROCESSING
-budesonidetablet, extended release68743-309DRUG FOR FURTHER PROCESSING
-mesalaminetablet, delayed release68743-476DRUG FOR FURTHER PROCESSING
Compare

Comparable companies in Italy

Enquiry

Common questions

Is Cosmo SpA FDA approved?
Cosmo SpA holds 1 FDA-registered establishment in Italy. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Cosmo SpA's drugs manufactured?
The FDA register lists LAINATE. Registered operations: analytical testing, finished drug manufacture.
What drugs does Cosmo SpA make?
4 products are listed under Cosmo SpA in the openFDA NDC Directory, most often as tablet, film coated; tablet, delayed release; tablet, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.